| Single-walled carbon nanohorns as promising nanotube-derived delivery systems to treat cancer A Moreno-Lanceta, M Medrano-Bosch, P Melgar-Lesmes Pharmaceutics 12 (9), 850, 2020 | 32 | 2020 |
| Nanoparticles to target and treat macrophages: the Ockham’s concept? M Medrano-Bosch, A Moreno-Lanceta, P Melgar-Lesmes Pharmaceutics 13 (9), 1340, 2021 | 21 | 2021 |
| RNF41 orchestrates macrophage-driven fibrosis resolution and hepatic regeneration A Moreno-Lanceta, M Medrano-Bosch, Y Fundora, M Perramón, J Aspas, ... Science translational medicine 15 (704), eabq6225, 2023 | 6 | 2023 |
| Atherosclerotic plaque development in mice is enhanced by myeloid ZEB1 downregulation MC Martinez-Campanario, M Cortés, A Moreno-Lanceta, L Han, C Ninfali, ... Nature Communications 14 (1), 8316, 2023 | 2 | 2023 |
| PPAR-γ Agonist GW1929 Targeted to Macrophages with Dendrimer–Graphene Nanostars Reduces Liver Fibrosis and Inflammation A Moreno-Lanceta, M Medrano-Bosch, B Simón-Codina, ... Pharmaceutics 15 (5), 1452, 2023 | 1 | 2023 |
| Liver-targeted nanoparticles delivering nitric oxide reduce portal hypertension in cirrhotic rats M Perramón, M Navalón-López, G Fernández-Varo, A Moreno-Lanceta, ... Biomedicine & Pharmacotherapy 171, 116143, 2024 | | 2024 |
| PERIHEPATIC IMPLANTS OF 3D ENGINEERED ENDOTHELIAL CELLS MATRICES PROTECT FIBROTIC LIVER FROM INJURY AND INFLAMMATION M Medrano-Bosch, A Moreno-Lanceta, B Simon-Codina, ... HEPATOLOGY 78, S257-S258, 2023 | | 2023 |
| Selective RNF41 restoration in hepatic macrophages from thioacetamide-induced fibrotic mice reduces liver fibrosis and inflammation A Moreno-Lanceta, M Medrano-Bosch, Y Fundora, M Perramón, J Aspas, ... Journal of Hepatology 78, S325, 2023 | | 2023 |
| 3D engineered perihepatic endothelial cell implants reduce fibrosis and inflammation, boosting liver regeneration in fibrotic hepatectomized mice M Medrano-Bosch, A Moreno-Lanceta, B Simón-Codina, L Macias-Muñoz, ... Journal of Hepatology 78, S333, 2023 | | 2023 |
| Polymeric Nanoparticles for Targeted Drug and Gene Delivery Systems A Moreno-Lanceta, M Medrano-Bosch, ER Edelman, P Melgar-Lesmes Pharmaceutical Nanobiotechnology for Targeted Therapy, 561-608, 2022 | | 2022 |
| LIVER-TARGETED NANOPARTICLES DELIVERING NITRIC OXIDE REDUCE PORTAL HYPERTENSION IN CIRRHOTIC RATS M Perramon, M Navalon-Lopez, G Fernandez-Varo, A Moreno Lanceta, ... HEPATOLOGY 76, S156-S157, 2022 | | 2022 |
| Selective induction of macrophage RNF41 stimulates liver regeneration in hepatectomized healthy and fibrotic mice A Moreno-Lanceta, M Medrano-Bosch, Y Fundora, M Perramón, J Aspas, ... Journal of Hepatology 77, S743-S744, 2022 | | 2022 |
| Perihepatic implantation of matrix-embedded endothelial cells reduce inflammation and collagen deposition in fibrotic mice M Medrano-Bosch, A Moreno-Lanceta, L Macias-Muñoz, E Edelman, ... Journal of Hepatology 77, S492, 2022 | | 2022 |
| Effect of engineered poly (beta-amino ester) nanoparticles containing a nitric oxide donor on systemic and portal hemodynamics M Perramón, M Navalón, GF Varo, B González, A Moreno-Lanceta, ... Journal of Hepatology 77, S106, 2022 | | 2022 |
| SELECTIVE MACROPHAGE RNF41 GENE SILENCING AGGRAVATES HEPATIC INJURY, INFLAMMATION AND COLLAGEN DEPOSITION IN FIBROTIC MICE A Moreno Lanceta, M Perramon, M Parra-Robert, E Edelman, ... HEPATOLOGY 74, 798A-799A, 2021 | | 2021 |
